Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments

Omar Usmani (London, United Kingdom)

Source: International Congress 2015 – PG2 Asthma and COPD
Session: PG2 Asthma and COPD
Session type: Postgraduate Course
Number: 41
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Omar Usmani (London, United Kingdom). Monitoring asthma – state-of-the-art physiological, imaging, and biomarker assessments. International Congress 2015 – PG2 Asthma and COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring asthma: state-of-the-art physiological, imaging, and biomarker assessments
Source: International Congress 2016 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2016



Monitoring asthma - state-of-the-art physiological, imaging and biomarker assessments
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018


COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
Source: Eur Respir J, 52 (5) 1801570; 10.1183/13993003.01570-2018
Year: 2018



Diagnostics of impaired lung function in asthmatics by MSCT-volumetry
Source: International Congress 2014 – Functional imaging
Year: 2014


An automated application for analysis of incremental exercise tests
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014

Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011


Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

Serial FEV1 measurements: an improved diagnostic tool for occupational asthma?
Source: International Congress 2017 – Asthma: clinical and epidemiologic characterisation
Year: 2017


Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015

LATE-BREAKING ABSTRACT: Evaluating dynamic oxygen-enhanced MRI biomarkers of lung function: Sensitivity to conventional COPD treatment
Source: Annual Congress 2013 –Functional imaging
Year: 2013


COPD and hypogonadism
Source: International Congress 2014 – Pathophysiological mechanisms at different scales
Year: 2014

Clinical prediction guides in COPD, a real life evaluation
Source: International Congress 2019 – Clinical implications of COPD management
Year: 2019

Exercise-induced bronchoconstriction in a school-age cohort: Prevalence, risk factors and utility of the Cooper test for its routine detection
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014

Monitoring asthma in children: clinical tools
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014



Assessing & monitoring airway diseases using imaging
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019


Diagnosis and assessment of asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=180
Year: 2003

Integration of EBC biomarkers into the pool of monitoring tools in pulmonology (potentials and limits)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007